BATS BZX Real-Time Price
As of 2:25pm ET
| -2.09 / -1.94%|
The 7 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 124.00, with a high estimate of 163.00 and a low estimate of 87.00. The median estimate represents a +17.20% increase from the last price of 105.80.
The current consensus among 8 polled investment analysts is to Buy stock in Agios Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.